The global lateral flow assay market was valued at $8,351.30 million in 2020 and is projected to reach $13,352.90 million by 2030 registering a CAGR of 4.70% from 2021 to 2030.
ELISpot and FluoroSpot Assays Industry Research Report Analysis by MRFR. The Market is expected to Reach USD 287 Million by 2023. The Global Market Analysis by Product, Application, End User, and Region - Forecast till 2023
ELISpot and FluoroSpot Assays Market Research Report Analysis by Market Research Future (MRFR). The Global Industry is anticipated to grow at a CAGR of 16.2% over the forecast period (2018 – 2023). The market is segmented by product, application, end user, and region - Forecast till 2023
The market for cell-based assays is driven by the preference over biochemical assays and animal models and the emergent 3D cell-based assay techniques in cell-based assays.
Infinium Global Research has added a new report on Global Cell based assays Market. The report predicts the market size of Cell based assays is expected to reach XX billion by 2023.
Rising prevalence of chronic and infectious diseases globally has led to the rise in cell viability assays market value. Data Bridge Market Research analyses that the cell viability assays market will exhibit a CAGR of around 7.34% for the forecast period of 2021-2028. https://www.databridgemarketresearch.com/reports/global-cell-viability-assays-market
Awareness towards preventive healthcare approaches, increase in the geriatric population regarding and growth in renal disorders and other chronic disorders will likely to accelerate the growth of the creatinine assay kits market in the forecast period of 2020-2027. On the other hand, favorable government initiatives towards the renal health will further boost various opportunities that will lead to the growth of the creatinine assay kits market in the above mentioned forecast period.
Significant increase in R&D pertaining to the development of novel drugs and biomarkers across the globe supplements the market growth for multiplex assays. Moreover, surge in incidence of diseases, including cancer, Alzheimer’s, cardiovascular diseases, and others propels the growth of the multiplex assay market.
Cell Based Assays Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
A new report avail by decisiondatabases.com for Genotyping Assay Market which provides an in-depth analysis during the forecast period. This report focuses on top manufactures with capacity, production, price, revenue and Market share. View Full Report & TOC @ https://bit.ly/2SLHLmp
Lateral flow assay kits are used for the early-stage diagnosis of diseases. According to the latest research by the company, the global lateral flow assay market is projected to account for over US$ 9.7 Bn in terms of value by the end of 2026.
Cell viability assays are a technology that is used to determine the overall health of cells and further measure the cell survival characteristics. It is a homogeneous method that is used to detect the number of dead or living cells in a sample regardless of the phase around the cell cycle. In other words, cell viability assays are an assessment of organ ability, cells, or tissues to improve viability. Cell viability assay is calculated using the ratio of total live/total cells.
The new Apoptosis Assays Market Report, offering growth, trends, and forecast for each segment along with regional and country analysis. The study has done with respect to market share, size, trend, growth, outlook, estimation and forecast period 2019-2025.
This report covers market size and forecasts of Protein Binding Assay, including the following market information: Global Protein Binding Assay Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Protein Binding Assay Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Protein Binding Assay Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) Global Protein Binding Assay Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
This report covers market size and forecasts of Glycated Albumin Assay, including the following market information: Global Glycated Albumin Assay Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kit) Global Glycated Albumin Assay Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kit) Global Glycated Albumin Assay Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (Kit) Global Glycated Albumin Assay Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (Kit)
Awareness towards preventive healthcare approaches, increase in the geriatric population regarding and growth in renal disorders and other chronic disorders will likely to accelerate the growth of the creatinine assay kits market in the forecast period of 2020-2027
Global neurobiology antibodies and assays market is anticipated to reach in USD 4.18 billion by 2023, at a CAGR of 10.2%. The report can facilitate the market leaders/new entrants during this market by providing them with the highest approximations of revenues for the general neurobiology antibodies and assays market and its subsegments.
Download Sample Brochure @ http://tinyurl.com/gmp7qfe The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Factor Assays testing closer to the patient, creating additional opportunities and challenges for suppliers.
The global stem cell assay market is expected to reach USD 1,363.3 Million by 2021 from USD 536.6 Million in 2016, at a CAGR of 20.5% from 2016 to 2021.
Big Market Research has announced a new Report Package "World Factor Assays Testing Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-world-factor-assays-testing-ambulatory-centers-commercial-labs-hospitals-physician-offices-poc-point-of-care-locations-competitive-landscape-country-segment-forecasts-innovative-technologies-inst-market The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/330942
Bharat Book Presents"Cell-Based Assays: World Market Prospects 2013-2023"Cellular assays form an important part of drug discovery and testing. With our report, you assess products, services, technologies (platforms) and companies in that fast-growing field.
Creatinine assay kits market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 315.76 million by 2027 growing at a CAGR of 5.90% in the above-mentioned forecast period. The innovation in the research and development of kidney disorders will help in driving the growth of the creatinine assay kits market.
A new report on Global Cell-based Assays Consumption 2016 Market Research Report seen on DecisionDatabases.com analyses the complete market. The industry sales & production volumes, industry’s trends are all discussed,explained and analysed.
The Global And China Custom Assays Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Custom Assays industry.
Lateral flow assay kits are used for the early-stage diagnosis of diseases. According to the latest research by the company, the global lateral flow assay market is projected to account for over US$ 9.7 Bn in terms of value by the end of 2026.
The Global And China High-density Multiplexed Diagnostic Assays Industry 2017 Market Research Report is a professional and in-depth study on the current state of the High-density Multiplexed Diagnostic Assays industry.
Lateral flow assay is defined as a diagnostic technique which involves antibodies and probe DNA biochemical interaction. This method ensures that the test conducted is highly simplified, with low costs and no requirement of any interference while the test is being conducted. The test can also be easily conducted by non-trained individuals as it is based on a highly user friendly form of testing.
Global Protein Assays Market Size 2018, By Type (Dye-binding Assays, Copper-ion-based Assays, Test Strip-based Assays, Other Protein Assays), Technology, Application (Drug Discovery and Development, Disease Diagnosis, Other Applications), End User, Region and Forecast 2019 to 2025
The global cell-based assays market is expected to reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, growing at a CAGR of 11.16% between 2015 and 2020.
Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) – Global Forecast to 2018 @ http://www.lifescienceindustryresearch.com/cell-based-assays-market-by-product-reagents-assay-kits-cytotoxicity-gpcr-cell-lines-plate-readers-hcs-hts-software-assay-development-services-application-drug-discovery-admet-end-u.html There has been a substantial rise in the costs to develop a new drug in recent years. This is specially observed when a new compound enters animal testing. The use of animals in experimentation is becoming dearer, due to limitations such as high costs involved in breeding and acquisition of animals, due to the complexity of procedures involved in the in vivo testing, and several other ethical issues and legal issues associated with it. Moreover the traditional biochemical assays also posses many limitations.
Big Market Research provides a new Report Package "Oxidative Stress Assay Market- Types, End Users, Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/oxidative-stress-assay-mnm-market Oxidative stress assays are widely used to determine the levels of oxidative stress markers in cultured cells used in research and bioproduction. The growth of the oxidative stress assays market is mainly driven by rapid growth in the biopharmaceutical industry, strong trend of R&D investments in pharmaceutical and biotechnology industries, technological advancements like high-content screening for drug discovery, and government funding for life science research. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/280886
The report "Multiplex Assays Market Product (Consumable (Kits & Reagents, Panels), Type 9nucleic Acid-Based, Protein-Based), Technology (PCR, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the multiplex assays market along with the estimates and forecasts of the revenue.
Creatinine assay kits market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 315.76 million by 2027 growing at a CAGR of 5.90% in the above-mentioned forecast period. The innovation in the research and development of kidney disorders will help in driving the growth of the creatinine assay kits market.
Infinium Global Research has added a new report on Global Cell-Based Assays Market. The report predicts the market size of Cell-Based Assays is expected to reach XX billion by 2023.
The Global ELISpot and FluoroSpot Assay Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027.
The Business Research Company provides a latest business intelligence research report on Cell Based Assays Industry 2021, depicts the nuts and bolts in current and future market. https://bit.ly/3ukwuYi
This new 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
This new 310-page report provides a comprehensive analysis of the European Endocrine Function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH. Complete report is available @ http://www.reportsnreports.com/reports/274320-2014-strategies-for-the-european-endocrine-function-testing-market.html .
C-Reactive Protein Test Market : Roche Diagnostics, EMD Millipore, Life technologies, Randox, Quest Diagnostics, Abaxis Inc., and others are some of the companies in this market. In 2010, Abaxis received FDA approval for its C-Reactive Protein (CRP) assay to be used with the Piccolo Xpress point-of-care analyzer. With the help of this, health care professionals would be able to conduct on site analysis rapidly for a variety of conditions such as inflammatory diseases infections, etc.
This new 327-page report contains 75 tables and provides analysis of the Global Endocrine Function Diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol Estradiol FSH HCG Gastrin LH Progesterone PTH/IO PTH Prolactin T3 T3 Uptake Free T3 T4 Free T4 TBG Testosterone Thyroglobulin Ab TPO Ab TSH Complete report is available @ http://www.reportsnreports.com/reports/274319-2014-strategies-for-the-global-endocrine-function-testing-market.html.
The report is intended as a reference/resource document that will facilitate identifying screening centers with certain capabilities or interests, and the direct comparison (benchmarking) of the screening centers surveyed. It is anticipated that the report will be of interest to 3rd parties seeking comparative data and a concise summary of information on academic outreach and non-profit screening (e.g. Large Pharma or Disease Foundations looking for potential screening collaborators; vendors seeking to identify suitable centers; or organizations considering setting up new centers). Get a report details @ http://www.rnrmarketresearch.com/academic-outreach-non-profit-screening-trends-2014-market-report.html .
The Global Transplant Diagnostics Market Is Projected to reach USD 753.9 Million by 2021 From USD 535.0 Million in 2016, at a CAGR of 7.1%, during 2016 to 2021
Market Research Future (MRFR) has published a report stating that the global cell viability market is marked to expand at a CAGR of 9.2% during the forecast period of 2018-2023
The increasing prevalence of chronic disorders, increasing technological advancements in the assay kits and analyzers, and increasing research in the field of vaccines are expected to be the primary factors affecting the market.
The study segments ELISpot and Fluorospot Assay industry in light of major classification such as product type, potential markets, application, and end-user.
The cell viability assays market is expected to reach USD 4.16 billion by 2023 from an estimated USD 2.78 billion in 2018, at a CAGR of 8.4%. The rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research and rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics are the key drivers for market growth.
North America is expected to account for the largest share of the global lateral flow assay market @ http://goo.gl/Q6R3HY . It is followed by Europe, Asia-Pacific, and RoW. However, markets in developed geographies like North America and Europe are expected to grow at lower CAGRs as compared to the Asia-Pacific. This is because the Asia-Pacific region is characterized by favorable factors for market growth, such as rising healthcare awareness, presence of less stringent regulations, improving healthcare infrastructure, and increasing demand for quality healthcare at low costs.
The global protein assays market is segmented based on type, product, technology, application, end user, and region. Download Sample at http://bit.ly/2MUwSY3 . The protein assays market by product is segmented into reagents, kits, and instruments & accessories. The reagents segment is expected to witness the highest growth during the forecast period, primarily due to the repeated purchases of reagents, unlike instruments that are considered a one-time investment.
The increasing prevalence of chronic disorders, increasing technological advancements in the assay kits and analyzers, and increasing research in the field of vaccines are expected to be the primary factors affecting the market.
Market Research Future (MRFR) has published a report stating that the global cell viability market is marked to expand at a CAGR of 9.2% during the forecast period of 2018-2023. Increasing incidences of individuals suffering from chronic diseases such as cancer and diabetes have induced high demand for technologically advanced diagnosis and treatment solutions in the healthcare sector
According to #TechSci Research report, Global Rapid Test Kit Market stood at USD23.44 billion in 2020 and expected to grow at steady CAGR of 8.14% by 2026. Gain More Insight: https://bit.ly/3vEVaM0 Get Sample Report: https://bit.ly/37y0udo Press Release: https://bit.ly/3rzXsfK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
“2014 Strategies for the Global Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual .
The hematology market stands as seventh largest market in the global in-vitro diagnostics market 2017 Complete Report available at: http://www.rnrmarketresearch.com/hematology-market-global-briefing-2017-including-automated-cell-counter-red-cell-indices-device-microsedimentation-centrifuge-blood-volume-measuring-device-occult-blood-test-platelet-aggregometer-erythrocyte-ries-inc-market-report.html